Author

Júlia Belone Lopes

h-index 2 View on Semantic Scholar

We have 2 of 14 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Clinicopathological factors associated with brain metastases development among breast cancer patients receiving neoadjuvant chemotherapy

Among patients treated with NAC for early-stage BC, residual nodal disease, inflammatory BC, and HER2+ or triple-negative subtype are associated with a higher risk of BrM development and whether BrM screening is warranted among patients with these high-risk features warrants evaluation.

Jie Zhu, I. Fernandes, Júlia Belone Lopes et al. · Journal of Neuro-Oncology · 0 citations

Open access Aug 2026

RMTC-07 OBESITY AND RISK OF BRAIN METASTASES AMONG PATIENTS DIAGNOSED WITH EARLY-STAGE BREAST CANCER: A POPULATION-BASED COHORT STUDY

In this large population-based cohort study, baseline obesity was not associated with risk of BrM, however, BMI when measured as a continuous variable, was associated with a significantly shorter time-to-development of BrM, a finding that warrants further study.

C. Murphy, Bo Zhang, Júlia Belone Lopes et al. · Neuro-Oncology Advances · 0 citations